Letter to the editor

Retina

Volumn 30, Issue 8, 2010, Pages 1323-1324

  Chhablani, Jay Kumar ^a   Narayanan, Raja ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; STEROID; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

CENTRAL SEROUS RETINOPATHY; CUSHING DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LETTER; RECURRENCE RISK; RHEUMATOID ARTHRITIS; THERAPY EFFECT; TREATMENT RESPONSE; DRUG ANTAGONISM; FLUORESCENCE ANGIOGRAPHY; INJECTION; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CENTRAL SEROUS CHORIORETINOPATHY; COLORING AGENTS; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INJECTIONS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77957553201     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181e46b09     Document Type: Letter

References (5)

1. Lim SJ, Roh MI, Kwon OW. Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 2010;30:100-106.
2. Bouzas EA, Scott MH, Masttorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993;111:1229-1233.
3. Wakakura M, Ishihawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984;68:329-331.
4. Piccolino FC, Borgia L, Zinicola E, et al. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995;9:324-332.
5. Werry H, Arends C. Untersuchung zur Objektivierung von Personlichkeitsmerkmalen bei Patienten mit Retinopathia centralis serosa. Klin Monatsbl Augenheilkd 1978;172:363-370.